Company profile: Quantitative Medicine
1.1 - Company Overview
Company description
- Provider of an in silico predictive modeling platform, Computational Research Engine (CoRE), for constructing, assessing, validating, and deploying highly accurate predictive models to efficiently guide testing and solve complex drug discovery optimization problems.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Quantitative Medicine
Datatrial
HQ: United Kingdom
Website
- Description: Provider of an integrated nowEDC system delivering data capture, verification and validation, query management, data extract, randomization, and real-time reporting. Easy to use, fully validated and highly configurable, its flexibility suits complex and adaptive trial designs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Datatrial company profile →
Deepcell
HQ: United States
Website
- Description: Provider of AI-powered single-cell classification and isolation solutions for basic and translational research, offering the REM-I platform combining high-resolution imaging, AI, and morphology-based sorting; the Human Foundation Model for real-time cell characterization; the Axon Data Suite for cloud storage, visualization, and analysis; plus advanced microfluidics and deep learning foundation models.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Deepcell company profile →
MedSciNet
HQ: Sweden
Website
- Description: Provider of tailor-made database applications for clinical trials, built and managed by an internet company, supporting well-organised, high-quality medical data to create preconditions for clinical researchers and other professionals to achieve medical breakthroughs and innovations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MedSciNet company profile →
Convergence CT
HQ: United States
Website
- Description: Provider of health informatics solutions, including online portals, data networks, and analytics for healthcare providers. Offers the Revalo Health Platform for secure federated queries of de-identified data across hospitals, the Connected Technologies Platform to manage access and stage data, medical research services, EMR/EHR systems, and real-world evidence data from Asia for life sciences companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Convergence CT company profile →
Cryoport
HQ: United States
Website
- Description: Provider of outsourced temperature-controlled shipping and logistics for biological materials, offering ISO 21973-compliant shipping systems across cryogenic, ultra-cold (dry ice), refrigerated and controlled room temperatures; IntegriCell cryopreservation; integrated BioServices and biostorage; consulting to de-risk biologics and cell & gene therapy supply chains; and comprehensive upstream/downstream supply chain management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cryoport company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Quantitative Medicine
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Quantitative Medicine
2.2 - Growth funds investing in similar companies to Quantitative Medicine
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Quantitative Medicine
4.2 - Public trading comparable groups for Quantitative Medicine
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →